Eli Lilly backs Absci with $100 million investment
Pharma giant Eli Lilly and Company is leading a $100 million investment into Vancouver-based biotech company Absci. Read more... |!| Vancouver
Pharma giant Eli Lilly and Company is leading a $100 million investment into Vancouver-based biotech company Absci. Read more... |!| Vancouver